BOI:EPA
Boiron SA
€18.70
0.00%
(0.00) 1D
Oct 30, 5:35:22 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
€18.75
High
€18.75
Low
€18.50
Mkt. cap
331.72M
Avg. vol.
6.91K
Volume
1.88K
P/E ratio
12.40
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
Open
€18.75
High
€18.75
Low
€18.50
Mkt. cap
331.72M
Avg. vol.
6.91K
Volume
1.88K
P/E ratio
12.40
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
History Says No 20-Year Stretch in the S&P 500 Has Lost Money Since 1950. Here's What the Worst One Returned.
TradingView
·
10 hours ago
The Dow Jones Index Closes 1.09% Lower
Yahoo Finance
·
9 hours ago
Okta Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA